{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T16:13:29Z","timestamp":1793981609228,"version":"4.8.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Egyptian Russian University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Cardiovascular diseases are the major cause of global mortality, and often require the concomitant use of a number of drugs to prevent and reduce these deaths. The challenge is to find effective and accurate methods for analyzing these drugs in plasma. This research introduces an innovative, sustainable HPLC-FLD method for the concurrent determination of bisoprolol (BIS), amlodipine besylate (AML), telmisartan (TEL), and atorvastatin (ATV) within human plasma. Chromatographic separation was achieved using an isocratic elution mode on a Thermo Hypersil BDS C18 column (150\u2009\u00d7\u20094.6\u00a0mm, 5.0\u00a0\u03bcm), while the mobile phase comprised of ethanol and 0.03\u00a0M potassium phosphate buffer (pH 5.2) in a 40:60 ratio, with a flow rate of 0.6 mL\/min. The eluate was analyzed using UV detection within the wavelength range of 210\u2013260\u00a0nm to confirm effective separation of the four cardiovascular drugs. For enhanced specificity, a fluorescence detector was set to 227ex\/298em for BIS, 294ex\/365em for TEL, 274ex\/378em for ATV, and 361ex\/442em for amlodipine. The method was validated following the International Council for Harmonisation (ICH) guidelines. Linearity was established within the ranges of 5\u2013100 ng\/mL for BIS and AML, 0.1\u20135 ng\/mL for TEL, and 10\u2013200 ng\/mL for ATV, ensuring accuracy and precision. The significant of the current work represented in introduction of a highly sensitive, and selective analytical method, utilizing an economical sample preparation strategy, for the simultaneous determination of four different cardiovascular drugs (bisoprolol, amlodipine, telmisartan, and atorvastatin) in spiked human plasma. The extraction of sample was carried by liquid-liquid extraction (LLE) and analyzed by LC-fluorescence detector. The chromatographic run was short (less than10 min) which is a greet economical value.<\/jats:p>","DOI":"10.1038\/s41598-025-94907-0","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T06:51:51Z","timestamp":1744267911000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Development and validation of a highly sensitive HPLC method for quantifying cardiovascular drugs in human plasma using dual detection"],"prefix":"10.1038","volume":"15","author":[{"given":"Khalid A. M.","family":"Attia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed H.","family":"Abdel-Monem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"Abdel-Raoof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr S.","family":"Eissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"key":"94907_CR1","first-page":"S61","volume":"23","author":"A Del Giudice","year":"2010","unstructured":"Del Giudice, A., Pompa, G. & Aucella, F. Hypertension in the elderly. J. Nephrol. 23, S61\u201371 (2010).","journal-title":"J. Nephrol."},{"key":"94907_CR2","doi-asserted-by":"publisher","first-page":"327","DOI":"10.4330\/wjc.v4.i12.327","volume":"4","author":"OS Ogah","year":"2012","unstructured":"Ogah, O. S. et al. Blood pressure, prevalence of hypertension and hypertension related complications in Nigerian Africans: A review. World J. Cardiol. 4, 327\u2013340 (2012).","journal-title":"World J. Cardiol."},{"key":"94907_CR3","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1038\/sj.jhh.1001345","volume":"16","author":"E Escobar","year":"2002","unstructured":"Escobar, E. Hypertension and coronary heart disease. J. Hum. Hypertens. 16, S61\u2013S63 (2002).","journal-title":"J. Hum. Hypertens."},{"key":"94907_CR4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.15420\/ecr.2019.11.1","volume":"14","author":"M Wajngarten","year":"2019","unstructured":"Wajngarten, M. & Sampaio Silva, G. Hypertension and stroke: update on treatment. Eur. Cardiol. Rev. 14, 111 (2019).","journal-title":"Eur. Cardiol. Rev."},{"key":"94907_CR5","doi-asserted-by":"publisher","unstructured":"He, F., Deng, Y. & Li, W. Coronavirus disease 2019: What we know? J. Med. Virol.  https:\/\/doi.org\/10.1002\/jmv.25766 (2020).","DOI":"10.1002\/jmv.25766"},{"key":"94907_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s40292-022-00506-9","volume":"29","author":"G Gallo","year":"2022","unstructured":"Gallo, G., Calvez, V., Savoia, C. & \u00b7 & Hypertension and COVID-19: current evidence and perspectives. High. Blood Press. Cardiovasc. Prev. 29, 115\u2013123 (2022).","journal-title":"High. Blood Press. Cardiovasc. Prev."},{"key":"94907_CR7","doi-asserted-by":"publisher","unstructured":"Seravalle, G. & Grassi, G. Essential hypertension. Prim. Autonom. Nerv. Syst. Fourth Ed. 467\u2013470. https:\/\/doi.org\/10.1016\/B978-0-323-85492-4.00096-X (2023).","DOI":"10.1016\/B978-0-323-85492-4.00096-X"},{"key":"94907_CR8","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.phrs.2017.10.003","volume":"128","author":"C Cuspidi","year":"2018","unstructured":"Cuspidi, C., Tadic, M., Grassi, G. & Mancia, G. Treatment of hypertension: the ESH\/ESC guidelines recommendations. Pharmacol. Res. 128, 315\u2013321 (2018).","journal-title":"Pharmacol. Res."},{"key":"94907_CR9","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1124\/pharmrev.120.000096","volume":"73","author":"S Xu","year":"2021","unstructured":"Xu, S. et al. Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies. Pharmacol. Rev. 73, 924\u2013967 (2021).","journal-title":"Pharmacol. Rev."},{"key":"94907_CR10","unstructured":"Alhabeeb, W., Mrabeti, S., Ahmed & Abdelsalam, A. I. Therapeutic properties of highly selective \u03b2-blockers with or without additional vasodilator properties: Focus on bisoprolol and nebivolol in patients with cardiovascular disease. Cardiovasc. Drugs Ther. 1, 3."},{"key":"94907_CR11","doi-asserted-by":"publisher","first-page":"478","DOI":"10.2165\/00003495-199141030-00009","volume":"41","author":"D Murdoch","year":"1991","unstructured":"Murdoch, D. & Heel, R. C. Amlodipine: a review of its pharmacodynamic and Pharmacokinetic properties, and therapeutic use in cardiovascular disease. Drugs 41, 478\u2013505 (1991).","journal-title":"Drugs"},{"key":"94907_CR12","doi-asserted-by":"crossref","unstructured":"Wishart, D. S. et al. DrugBank: a comprehensive resource for in Silico drug discovery and exploration. Nucleic Acids Res. 34, (2006).","DOI":"10.1093\/nar\/gkj067"},{"key":"94907_CR13","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1582-4934.2001.tb00172.x","volume":"5","author":"C Stancu","year":"2001","unstructured":"Stancu, C. & Sima, A. Statins: mechanism of action and effects. J. Cell. Mol. Med. 5, 378\u2013387 (2001).","journal-title":"J. Cell. Mol. Med."},{"key":"94907_CR14","doi-asserted-by":"crossref","unstructured":"Unger, T. et al. International society of hypertension global hypertension practice guidelines. Hypertension 75, 1334\u20131357 (2020).","DOI":"10.1161\/HYPERTENSIONAHA.120.15026"},{"key":"94907_CR15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.saa.2018.11.014","volume":"210","author":"R Magdy","year":"2019","unstructured":"Magdy, R., Hemdan, A., Fares, N. V. & Farouk, M. Determination of amlodipine and atorvastatin mixture by different spectrophotometric methods with or without regression equations. Spectrochim. Acta Mol. Biomol. Spectrosc. 210, 203\u2013211 (2019).","journal-title":"Spectrochim Acta Mol. Biomol. Spectrosc."},{"key":"94907_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43094-021-00377-2","volume":"7","author":"IO Abu Reid","year":"2021","unstructured":"Abu Reid, I. O., Farid, H. M. & Eltayeb, S. O. Simple spectrophotometric methods for the determination of amlodipine and Atorvastatin in bulk and tablets. Futur. J. Pharm. Sci. 7, 1\u20138 (2021).","journal-title":"Futur J. Pharm. Sci."},{"key":"94907_CR17","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.saa.2011.08.005","volume":"83","author":"HW Darwish","year":"2011","unstructured":"Darwish, H. W., Hassan, S. A., Salem, M. Y. & El-Zeiny, B. A. Three different spectrophotometric methods manipulating ratio spectra for determination of binary mixture of amlodipine and atorvastatin. Spectrochim. Acta Mol. Biomol. Spectrosc. 83, 140\u2013148 (2011).","journal-title":"Spectrochim Acta Mol. Biomol. Spectrosc."},{"key":"94907_CR18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.saa.2012.11.079","volume":"104","author":"HW Darwish","year":"2013","unstructured":"Darwish, H. W., Hassan, S. A., Salem, M. Y. & El-Zeany, B. A. Three different methods for determination of binary mixture of amlodipine and Atorvastatin using dual wavelength spectrophotometry. Spectrochim. Acta Mol. Biomol. Spectrosc. 104, 70\u201376 (2013).","journal-title":"Spectrochim Acta Mol. Biomol. Spectrosc."},{"key":"94907_CR19","doi-asserted-by":"crossref","unstructured":"Khan, M. R. & Jain, D. Simultaneous spectrophotometric determination of Atorvastatin calcium and amlodipine besylate in tablets. Indian J. Pharm. Sci. 68, (2006).","DOI":"10.4103\/0250-474X.27846"},{"key":"94907_CR20","first-page":"137","volume":"9","author":"SA Kanchana","year":"2010","unstructured":"Kanchana, S. A., Ajithadas, A., Niraimathi, V. & Suresh, A. J. Simultaneous spectrophotometric Estimation of Telmisartan and amlodipine in tablet dosage form. J. Pharm. Res. 9, 137\u2013140 (2010).","journal-title":"J. Pharm. Res."},{"key":"94907_CR21","first-page":"1274","volume":"3","author":"MS Kondawar","year":"2011","unstructured":"Kondawar, M. S., Kamble, K. G., Raut, K. S. & Maharshi, K. H. UV spectrophotometric Estimation of amlodipine besylate and tlmisartan in bulk drug and dosage form by multiwavelength analysis. Int. J. Chem.Tech. Res. 3, 1274\u20131278 (2011).","journal-title":"Int. J. ChemTech Res."},{"key":"94907_CR22","first-page":"133","volume":"2","author":"KP Hirpara","year":"2012","unstructured":"Hirpara, K. P., Dave, V. M., Faldu, D. S. & Patel, D. B. UV-spectrophotometric determination for simultaneous estimation of amlodipine besylate and telmisartan in combination. J. Pharm. Sci. Bio Res. 2, 133 (2012).","journal-title":"J. Pharm. Sci. Bio Res."},{"key":"94907_CR23","first-page":"1218","volume":"3","author":"HK Golher","year":"2010","unstructured":"Golher, H. K. & Pillai, S. Simultaneous estimation of amlodipine besylate and telmisartan by UV-spectrophotometry. Res. J. Pharm. Technol. 3, 1218\u20131221 (2010).","journal-title":"Res. J. Pharm. Technol."},{"key":"94907_CR24","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/bio.2638","volume":"29","author":"TS Belal","year":"2014","unstructured":"Belal, T. S., Mahrous, M. S., Abdel-Khalek, M. M., Daabees, H. G. & Khamis, M. M. Validated spectrofluorimetric determination of two pharmaceutical antihypertensive mixtures containing amlodipine besylate together with either Candesartan cilexetil or Telmisartan. Luminescence 29, 893\u2013900 (2014).","journal-title":"Luminescence"},{"key":"94907_CR25","first-page":"513","volume":"1","author":"RB Kakde","year":"2008","unstructured":"Kakde, R. B., Kotak, V. H., Barsagade, A. G., Chaudhary, N. K. & Kale, D. L. Spectrophotometric method for simultaneous Estimation of amlodipine besylate and Bisoprolol fumarate in pharmaceutical preparations. Res. J. Pharm. Technol. 1, 513\u2013515 (2008).","journal-title":"Res. J. Pharm. Technol."},{"key":"94907_CR26","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1093\/jaoacint\/qsac018","volume":"105","author":"S Ramzy","year":"2022","unstructured":"Ramzy, S., Abdelazim, A. H. & Shahin, M. Quantitative analysis of two pharmaceutical combinations containing amlodipine with either Bisoprolol or Candesartan using different UV spectrophotometric methods. J. AOAC Int. 105, 1200\u20131204 (2022).","journal-title":"J. AOAC Int."},{"key":"94907_CR27","first-page":"10","volume":"7","author":"AM El-Didamonyp","year":"2015","unstructured":"El-Didamonyp, A. M. 1p, Hafeezp2p, S. M. & Saadp, A. A. Extraction-spectrophotometric determination of some antihypertensive drugs in pharmaceutical and biological fluids using two sulphonphthalein dyes. Int. J. App Pharm. 7, 10\u201317 (2015).","journal-title":"Int. J. App Pharm."},{"key":"94907_CR28","doi-asserted-by":"crossref","unstructured":"Sahu, R. & Patel, V. Simultaneous spectrophotometric determination of amlodipine besylate and Atorvastatin calcium in binary mixture. Indian J. Pharm. Sci. 69, (2007).","DOI":"10.4103\/0250-474X.32119"},{"key":"94907_CR29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3329\/dujps.v12i1.16298","volume":"12","author":"S Neeli","year":"2013","unstructured":"Neeli, S., Anuganti, H., Puvvadi, S. B. R. & Subrahmanyam, C. V. S. First derivative synchronous spectrofluorimetric quantification of Telmisartan\/amlodipine besylate combination in tablets. Dhaka Univ. J. Pharm. Sci. 12, 35\u201340 (2013).","journal-title":"Dhaka Univ. J. Pharm. Sci."},{"key":"94907_CR30","doi-asserted-by":"publisher","first-page":"122114","DOI":"10.1016\/j.saa.2022.122114","volume":"287","author":"KAM Attia","year":"2023","unstructured":"Attia, K. A. M., Abdel-Monem, A. H., Abdel-Raoof, A. M. & Eissa, A. S. Novel deconvoluted synchronous spectrofluorimetric method for simultaneous determination of bisoprolol and atorvastatin as single or co-administrated drugs in bulk and plasma; green assessment. Spectrochim. Acta Mol. Biomol. Spectrosc. 287, 122114 (2023).","journal-title":"Spectrochim Acta Mol. Biomol. Spectrosc."},{"key":"94907_CR31","first-page":"172","volume":"5","author":"AI Badran","year":"2015","unstructured":"Badran, A. I., EL-Fatatry, H. M. & Hammad, S. F. Simultaneous estimation of telmisartan and amlodipine by second derivative spectrophotometric method and first derivative ratiospectrophotometric method. Am. J. Pharm. Tech. Res. 5, 172\u2013189 (2015).","journal-title":"Am. J. Pharm. Tech. Res."},{"key":"94907_CR32","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1590\/S1984-82502014000200012","volume":"50","author":"PD Anumolu","year":"2014","unstructured":"Anumolu, P. D., Neeli, S., Anuganti, H., Ranganatham, S. B. P. & Satya, S. C. V. Development of dissolution test method for a telmisartan\/amlodipine besylate combination using synchronous derivative spectrofluorimetry. Brazil. J. Pharm. Sci. 50, 329\u2013336 (2014).","journal-title":"Brazilian J. Pharm. Sci."},{"key":"94907_CR33","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4137\/ACI.S12921","volume":"8","author":"BA Moussa","year":"2013","unstructured":"Moussa, B. A., El-Zaher, A. A., Mahrouse, M. A. & Ahmed, M. S. Simultaneous determination of amlodipine besylate and Atorvastatin calcium in binary mixture by spectrofluorimetry and HPLC coupled with fluorescence detection. Anal. Chem. Insights  8, 107\u2013115 (2013).","journal-title":"Anal. Chem. Insights"},{"key":"94907_CR34","doi-asserted-by":"publisher","first-page":"117430","DOI":"10.1016\/j.saa.2019.117430","volume":"224","author":"JJ Nasr","year":"2020","unstructured":"Nasr, J. J. & Shalan, S. Simultaneous estimation of amlodipine and atorvastatin by micelle-augmented first derivative synchronous spectrofluorimetry and multivariate analysis. Spectrochim. Acta Mol. Biomol. Spectrosc. 224, 117430 (2020).","journal-title":"Spectrochim Acta Mol. Biomol. Spectrosc."},{"key":"94907_CR35","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jchromb.2010.12.007","volume":"879","author":"O Gonzalez","year":"2011","unstructured":"Gonzalez, O. et al. Development of an LC\u2013MS\/MS method for the quantitation of 55 compounds prescribed in combined cardiovascular therapy. J. Chromatogr. B  879, 243\u2013252 (2011).","journal-title":"J. Chromatogr. B"},{"key":"94907_CR36","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1093\/jaoacint\/qsab079","volume":"104","author":"PB Prajapati","year":"2021","unstructured":"Prajapati, P. B., Patel, A. & Shah, S. A. Risk and DoE-based DMAIC principle to the multipurpose-RP-HPLC method for synchronous Estimation of anti-hypertensive drugs using AQbD approach. J. AOAC Int. 104, 1442\u20131452 (2021).","journal-title":"J. AOAC Int."},{"key":"94907_CR37","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1097\/FJC.0000000000001105","volume":"78","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. Monitoring antihypertensive medication adherence by liquid chromatography\u2013tandem mass spectrometry: method establishment and clinical application. J. Cardiovasc. Pharmacol. 78, 581\u2013596 (2021).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"94907_CR38","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1093\/chromsci\/bmab070","volume":"60","author":"P Prajapati","year":"2022","unstructured":"Prajapati, P., Patel, A. & Shah, S. Application of DoE-based analytical QRM to development of the multipurpose RP-HPLC method for estimation of multiple FDC products of telmisartan using enhanced AQbD approach. J. Chromatogr. Sci. 60, 525\u2013537 (2022).","journal-title":"J. Chromatogr. Sci."},{"key":"94907_CR39","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/10826076.2012.738622","volume":"37","author":"AA Elshanawane","year":"2014","unstructured":"Elshanawane, A. A., Abdelaziz, L. M., Kamal, M. M. & Hafez, H. M. Quantitative determination of telmisartan, ramipril, amlodipine besylate, and atorvastatin calcium by HPLC. J. Liq Chromatogr. Relat. Technol. 37, 195\u2013206 (2014).","journal-title":"J. Liq Chromatogr. Relat. Technol."},{"key":"94907_CR40","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s10337-020-03937-5","volume":"83","author":"AA Habib","year":"2020","unstructured":"Habib, A. A., Hammad, S. F., Megahed, S. M. & Kamal, A. H. Innovative quality by design approach for development of green micellar HPLC method for simultaneous determination of atorvastatin and amlodipine. Chromatographia 83, 1221\u20131231 (2020).","journal-title":"Chromatographia"},{"key":"94907_CR41","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1093\/jaoacint\/qsaa136","volume":"104","author":"SM Elonsy","year":"2021","unstructured":"Elonsy, S. M., Yazbi, E., Shaalan, F. A., Ahmed, R. A., Belal, T. S. & H. M. & Application of MEKC and UPLC with fluorescence detection for simultaneous determination of amlodipine besylate and bisoprolol fumarate. J. AOAC Int. 104, 339\u2013347 (2021).","journal-title":"J. AOAC Int."},{"key":"94907_CR42","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.jchromb.2011.01.004","volume":"879","author":"Y Shah","year":"2011","unstructured":"Shah, Y. et al. Simultaneous determination of rosuvastatin and atorvastatin in human serum using RP-HPLC\/UV detection: method development, validation and optimization of various experimental parameters. J. Chromatogr. B  879, 557\u2013563 (2011).","journal-title":"J. Chromatogr. B"},{"key":"94907_CR43","doi-asserted-by":"crossref","unstructured":"Borman, P. & Elder, D. Q2(R1) validation of analytical procedures. ICH Qual. Guidelines 127\u2013166 (2017).","DOI":"10.1002\/9781118971147.ch5"},{"key":"94907_CR44","doi-asserted-by":"crossref","unstructured":"Dong, M. W. HPLC and UHPLC for Practicing Scientists (Wiley, 2019).","DOI":"10.1002\/9781119313786"},{"key":"94907_CR45","doi-asserted-by":"crossref","unstructured":"Moldoveanu, S. C. & David, V. Essentials in Modern HPLC Separations (Elsevier, 2022).","DOI":"10.1016\/B978-0-323-91177-1.00009-0"},{"key":"94907_CR46","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1080\/10826076.2010.484356","volume":"33","author":"M Swartz","year":"2010","unstructured":"Swartz, M. HPLC detectors: a brief review. J. Liq Chromatogr. Relat. Technol. 33, 1130\u20131150 (2010).","journal-title":"J. Liq Chromatogr. Relat. Technol."},{"key":"94907_CR47","doi-asserted-by":"crossref","unstructured":"McClellan, K. J. & Markham, A. Telmisartan Drugs 56, (1998).","DOI":"10.2165\/00003495-199856060-00007"},{"key":"94907_CR48","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.2165\/00003088-200342130-00005","volume":"42","author":"H Lennern\u00e4s","year":"2003","unstructured":"Lennern\u00e4s, H. Clinical pharmacokinetics of atorvastatin. Clin. Pharmacokinet. 42, 1141\u20131160 (2003).","journal-title":"Clin. Pharmacokinet."},{"key":"94907_CR49","doi-asserted-by":"publisher","first-page":"22","DOI":"10.2165\/00003088-199222010-00003","volume":"22","author":"PA Meredith","year":"1992","unstructured":"Meredith, P. A. & Elliott, H. L. Clinical pharmacokinetics of amlodipine. Clin. Pharmacokinet. 22, 22\u201331 (1992).","journal-title":"Clin. Pharmacokinet."},{"key":"94907_CR50","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/j.1552-4604.1986.tb02959.x","volume":"26","author":"G Leopold","year":"1986","unstructured":"Leopold, G., Pabst, J., Ungeth\u00fcm, W. & B\u00fchring, K. Basic pharmacokinetics of bisoprolol, a new highly beta1-selective adrenoceptor antagonist. J. Clin. Pharmacol. 26, 616\u2013621 (1986).","journal-title":"J. Clin. Pharmacol."},{"key":"94907_CR51","unstructured":"Medicines Agency E. ICH guideline M10 on bioanalytical method validation 4 step 2b 5. (2019)."},{"key":"94907_CR52","doi-asserted-by":"publisher","first-page":"191","DOI":"10.4236\/pp.2013.42027","volume":"4","author":"CM Lv","year":"2013","unstructured":"Lv, C. M. et al. Determination of amlodipine in human plasma by LC-MS\/MS and its bioequivalence study in healthy Chinese subjects. Pharmacol. Pharm. 4, 191\u2013200 (2013).","journal-title":"Pharmacol. Pharm."},{"key":"94907_CR53","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jchromb.2005.09.021","volume":"828","author":"P Li","year":"2005","unstructured":"Li, P. et al. Determination of telmisartan in human plasma by liquid chromatography\u2013tandem mass spectrometry. J. Chromatogr. B  828, 126\u2013129 (2005).","journal-title":"J. Chromatogr. B"},{"key":"94907_CR54","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1093\/chromsci\/bms056","volume":"50","author":"ST Ulu","year":"2012","unstructured":"Ulu, S. T. & Aydo\u01e7mu\u015f, Z. An HPLC method for the determination of bisoprolol in human plasma and its application to a pharmacokinetic study. J. Chromatogr. Sci. 50, 615\u2013619 (2012).","journal-title":"J. Chromatogr. Sci."},{"key":"94907_CR55","doi-asserted-by":"publisher","first-page":"117435","DOI":"10.1016\/j.trac.2023.117435","volume":"170","author":"MS Eissa","year":"2024","unstructured":"Eissa, M. S. & Darweish, E. Insights on ecological spectroscopic techniques recently adopted for pharmaceutical analysis: A comprehensive review from the perspective of greenness assessment metrics systems application. TRAC Trends Anal. Chem. 170, 117435 (2024).","journal-title":"TRAC Trends Anal. Chem."},{"key":"94907_CR56","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.talanta.2018.01.013","volume":"181","author":"J P\u0142otka-Wasylka","year":"2018","unstructured":"P\u0142otka-Wasylka, J. A new tool for the evaluation of the analytical procedure: green analytical procedure index. Talanta 181, 204\u2013209 (2018).","journal-title":"Talanta"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94907-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94907-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94907-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T08:09:17Z","timestamp":1744272557000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94907-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["94907"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-94907-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,10]]},"assertion":[{"value":"27 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12229"}}